Cirrhosis News and Research

Latest Cirrhosis News and Research

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Galectin submits GR-MD-02 IND application with FDA for treatment of liver fibrosis

Galectin submits GR-MD-02 IND application with FDA for treatment of liver fibrosis

ArQule, Daiichi Sankyo initiate enrollment in tivantinib Phase 3 trial for hepatocellular carcinoma

ArQule, Daiichi Sankyo initiate enrollment in tivantinib Phase 3 trial for hepatocellular carcinoma

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Scientists identify genetic process in which normal liver cells transform into cancerous ones

Scientists identify genetic process in which normal liver cells transform into cancerous ones

Shorter surveillance intervals detect HCC earlier

Shorter surveillance intervals detect HCC earlier

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial

Early hepatitis B vaccination may be ineffective in teenagers

Early hepatitis B vaccination may be ineffective in teenagers

Scientists develop playbook to end devastating impact of fibrotic diseases

Scientists develop playbook to end devastating impact of fibrotic diseases

Adolescents may lose hepatitis B virus protection despite vaccination as infants

Adolescents may lose hepatitis B virus protection despite vaccination as infants

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites

PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites

Raising transfusion threshold improves acute upper GI bleeding outcomes

Raising transfusion threshold improves acute upper GI bleeding outcomes

SVR associated with prolonged overall survival in patients with chronic HCV infection

SVR associated with prolonged overall survival in patients with chronic HCV infection

Hair ethyl glucuronide detects even modest drinking

Hair ethyl glucuronide detects even modest drinking

SR9238 compound can reverse effects of fatty liver disease

SR9238 compound can reverse effects of fatty liver disease

Long-term antiviral HBV treatment advocated

Long-term antiviral HBV treatment advocated

Researchers discover a trigger by which the HCV enters liver cells

Researchers discover a trigger by which the HCV enters liver cells

Baby boomers with liver cancer drive demand for liver transplantation

Baby boomers with liver cancer drive demand for liver transplantation

Tenofovir DF safe and effective in treating adolescents with HBV

Tenofovir DF safe and effective in treating adolescents with HBV

Men should see a doctor and be proactive about their health, say UAB experts

Men should see a doctor and be proactive about their health, say UAB experts

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.